logo
welcome
Telegraph

Telegraph

‘My Alzheimer’s was being treated with donanemab – but now I’m in limbo’

Telegraph
Summary
Nutrition label

66% Informative

Peter Almond , 78 , was diagnosed with mild cognitive impairment ( MCI ) in 2018 .

MCI is sometimes although not always an early sign of Alzheimer’s.

A treatment centre in Guildford was trialling new drug treatments for dementia.

It has been shown in clinical trials to slow the decline in memory and thinking by around a third .

However, now donanemab trial has ended in September and he doesn’t know what to expect.

VR Score

68

Informative language

65

Neutral language

87

Article tone

informal

Language

English

Language complexity

33

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links